Histone modifications and a choice of variant: A language that helps the genome express itself

F1000Prime Reports

Volumn 6, Issue , 2014, Pages

  Gurard Levin, Zachary A ^a,b,c,d   Almouzni, Geneviève ^a,b,c,d  

^a INSTITUT CURIE   (France)

^b CNRS   (France)

^c INSTITUT CURIE   (France)

^d SORBONNE UNIVERSITÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CHROMATIN ASSEMBLY FACTOR 1; DNA BINDING PROTEIN; NUCLEOTIDE DERIVATIVE; POLYCOMB GROUP PROTEIN; PROTEIN VARIANT;

ARTICLE; CANCER GROWTH; CELL CYCLE; CELL FUNCTION; CHROMATIN IMMUNOPRECIPITATION; CHROMATIN STRUCTURE; DNA SEQUENCE; DNA SYNTHESIS; ENZYME ACTIVITY; ENZYME MODIFICATION; ENZYME SPECIFICITY; GENE EXPRESSION; GENE MUTATION; GENOME; GENOMIC INSTABILITY; HISTONE MODIFICATION; HUMAN;

EID: 84907043495     PISSN: 20517599     EISSN: 20517599     Source Type: Journal    
DOI: 10.12703/P6-76     Document Type: Article

References (109)

1. Allfrey VG, Mirsky AE: Structural Modifications of Histones and their Possible Role in the Regulation of RNA Synthesis. Science 1964, 144:559.
2. Allfrey VG, Faulkner R, Mirsky AE: Acetylation and methylation of histones and their possible role in the regulation of RNA synthesis. Proc Natl Acad Sci USA 1964, 51:786-94.
3. Murray K: The occurence of epsilon-N-methyl lysine in histones. Biochemistry 1964, 3:10-5.
4. Stevely WS, Stocken LA: Phosphorylation of rat-thymus histone. Biochem J 1966, 100:20C-1C.
5. Han M, Kim UJ, Kayne P, Grunstein M: Depletion of histone H4 and nucleosomes activates the PHO5 gene in Saccharomyces cerevisiae. EMBO J 1988, 7:2221-8.
6. Johnson LM, Kayne PS, Kahn ES, Grunstein M: Genetic evidence for an interaction between SIR3 and histone H4 in the repression of the silent mating loci in Saccharomyces cerevisiae. Proc Natl Acad Sci USA 1990, 87:6286-90.
7. Turner BM, Birley AJ, Lavender J: Histone H4 isoforms acetylated at specific lysine residues define individual chromosomes and chromatin domains in Drosophila polytene nuclei. Cell 1992, 69:375-84.
8. Travis GH, Colavito-Shepanski M, Grunstein M: Extensive purification and characterization of chromatin-bound histone acet-yltransferase from Saccharomyces cerevisiae. J Biol Chem 1984, 259:14406-12.
9. Kleff S, Andrulis ED, Anderson CW, Sternglanz R: Identification of a gene encoding a yeast histone H4 acetyltransferase. J Biol Chem 1995, 270:24674-7.
10. Brownell JE, Zhou J, Ranalli T, Kobayashi R, Edmondson DG, Roth SY, Allis CD: Tetrahymena histone acetyltransferase A: a homolog to yeast Gcn5p linking histone acetylation to gene activation. Cell 1996, 84:843-51.
11. Taunton J, Hassig CA, Schreiber SL: A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p. Science 1996, 272:408-11.
12. Rea S, Eisenhaber F, O'Carroll D, Strahl BD, Sun ZW, Schmid M, Opravil S, Mechtler K, Ponting CP, Allis CD, Jenuwein T: Regulation of chromatin structure by site-specific histone H3 methyltransferases. Nature 2000, 406:593-9.
13. Shi Y, Lan F, Matson C, Mulligan P, Whetstine JR, Cole PA, Casero RA, Shi Y: Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell 2004, 119:941-53.
14. Turner BM: Acetylation and deacetylation of histone H4 continue through metaphase with depletion of more-acetylated isoforms and altered site usage. Exp Cell Res 1989, 182:206-14.
15. Strahl BD, Allis CD: The language of covalent histone modifications. Nature 2000, 403:41-5.
16. Jenuwein T, Allis CD: Translating the histone code. Science 2001, 293:1074-80.
17. Turner BM: Histone acetylation and an epigenetic code. Bioessays 2000, 22:836-45.
18. Dhall A, Chatterjee C: Chemical approaches to understand the language of histone modifications. ACS Chem Biol 2011, 6:987-99.
19. Bojang P, Ramos KS: The promise and failures of epigenetic therapies for cancer treatment. Cancer Treat Rev 2014, 40:153-69.
20. Taverna SD, Li H, Ruthenburg AJ, Allis CD, Patel DJ: How chromatin-binding modules interpret histone modifications: lessons from professional pocket pickers. Nat Struct Mol Biol 2007, 14:1025-40.
21. Szenker E, Ray-Gallet D, Almouzni G: The double face of the histone variant H3.3. Cell Res 2011, 21:421-34.
22. Filipescu D, Szenker E, Almouzni G: Developmental roles of histone H3 variants and their chaperones. Trends Genet 2013, 29:630-40.
23. Bannister AJ, Kouzarides T: Regulation of chromatin by histone modifications. Cell Res 2011, 21:381-95.
24. Rivera C, Gurard-Levin ZA, Almouzni G, Loyola A: Histone lysine methylation and chromatin replication. Biochim Biophys Acta 2014.
25. Fuchs SM, Strahl BD: Antibody recognition of histone posttranslational modifications: emerging issues and future prospects. Epigenomics 2011, 3:247-9.
26. Barski A, Cuddapah S, Cui K, Roh T, Schones DE, Wang Z, Wei G, Chepelev I, Zhao K: High-resolution profiling of histone methylations in the human genome. Cell 2007, 129:823-37.
27. Mikkelsen TS, Ku M, Jaffe DB, Issac B, Lieberman E, Giannoukos G, Alvarez P, Brockman W, Kim T, Koche RP, Lee W, Mendenhall E, O'Donovan A, Presser A, Russ C, Xie X, Meissner A, Wernig M, Jaenisch R, Nusbaum C, Lander ES, Bernstein BE: Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature 2007, 448:553-60.
28. Johnson DS, Mortazavi A, Myers RM, Wold B: Genome-wide mapping of in vivo protein-DNA interactions. Science 2007, 316:1497-502.
29. Brinkman AB, Gu H, Bartels, Stefanie J J, Zhang Y, Matarese F, Simmer F, Marks H, Bock C, Gnirke A, Meissner A, Stunnenberg HG: Sequential ChIP-bisulfite sequencing enables direct genomescale investigation of chromatin and DNA methylation crosstalk. Genome Res 2012, 22:1128-38.
30. Byrum SD, Raman A, Taverna SD, Tackett AJ: ChAP-MS: a method for identification of proteins and histone posttranslational modifications at a single genomic locus. Cell Rep 2012, 2:198-205.
31. Alabert C, Bukowski-Wills J, Lee S, Kustatscher G, Nakamura K, de Lima Alves, Flavia, Menard P, Mejlvang J, Rappsilber J, Groth A: Nascent chromatin capture proteomics determines chromatin dynamics during DNA replication and identifies unknown fork components. Nat Cell Biol 2014, 16:281-93.
32. Sirbu BM, McDonald WH, Dungrawala H, Badu-Nkansah A, Kavanaugh GM, Chen Y, Tabb DL, Cortez D: Identification of proteins at active, stalled, and collapsed replication forks using isolation of proteins on nascent DNA (iPOND) coupled with mass spectrometry. J Biol Chem 2013, 288:31458-67.
33. Maeder ML, Angstman JF, Richardson ME, Linder SJ, Cascio VM, Tsai SQ, Ho QH, Sander JD, Reyon D, Bernstein BE, Costello JF, Wilkinson MF, Joung JK: Targeted DNA demethylation and activation of endogenous genes using programmable TALETET1 fusion proteins. Nat Biotechnol 2013, 31:1137-42.
34. Mendenhall EM, Williamson KE, Reyon D, Zou JY, Ram O, Joung JK, Bernstein BE: Locus-specific editing of histone modifications at endogenous enhancers. Nat Biotechnol 2013, 31:1133-6.
35. Konermann S, Brigham MD, Trevino AE, Hsu PD, Heidenreich M, Le Cong, Platt RJ, Scott DA, Church GM, Zhang F: Optical control of mammalian endogenous transcription and epigenetic states. Nature 2013, 500:472-6.
36. Fuchs SM, Krajewski K, Baker RW, Miller VL, Strahl BD: Influence of combinatorial histone modifications on antibody and effector protein recognition. Curr Biol 2011, 21:53-8.
37. Simon MD, Chu F, Racki LR, de la Cruz, Cecile C, Burlingame AL, Panning B, Narlikar GJ, Shokat KM: The site-specific installation of methyl-lysine analogs into recombinant histones. Cell 2007, 128:1003-12.
38. Neumann H, Hancock SM, Buning R, Routh A, Chapman L, Somers J, Owen-Hughes T, van Noort J, Rhodes D, Chin JW: A method for genetically installing site-specific acetylation in recombinant histones defines the effects of H3 K56 acetylation. Mol Cell 2009, 36:153-63.
39. Kee J, Villani B, Carpenter LR, Muir TW: Development of stable phosphohistidine analogues. J Am Chem Soc 2010, 132:14327-9.
40. Chatterjee C, McGinty RK, Fierz B, Muir TW: Disulfide-directed histone ubiquitylation reveals plasticity in hDot1L activation. Nat Chem Biol 2010, 6:267-9.
41. Rothbart SB, Krajewski K, Strahl BD, Fuchs SM: Peptide microarrays to interrogate the "histone code". Meth Enzymol 2012, 512:107-35.
42. Bock I, Dhayalan A, Kudithipudi S, Brandt O, Rathert P, Jeltsch A: Detailed specificity analysis of antibodies binding to modified histone tails with peptide arrays. Epigenetics 2011, 6:256-63.
43. Egelhofer TA, Minoda A, Klugman S, Lee K, Kolasinska-Zwierz P, Alekseyenko AA, Cheung M, Day DS, Gadel S, Gorchakov AA, Gu T, Kharchenko PV, Kuan S, Latorre I, Linder-Basso D, Luu Y, Ngo Q, Perry M, Rechtsteiner A, Riddle NC, Schwartz YB, Shanower GA, Vielle A, Ahringer J, Elgin, Sarah C R, Kuroda MI, Pirrotta V, Ren B, Strome S, Park PJ, et al.: An assessment of histone-modification antibody quality. Nat Struct Mol Biol 2011, 18:91-3.
44. Gurard-Levin ZA, Kilian KA, Kim J, Bähr K, Mrksich M: Peptide arrays identify isoform-selective substrates for profiling endogenous lysine deacetylase activity. ACS Chem Biol 2010, 5:863-73.
45. Ibáñez G, McBean JL, Astudillo YM, Luo M: An enzyme-coupled ultrasensitive luminescence assay for protein methyltransferases. Anal Biochem 2010, 401:203-10.
46. Garske AL, Craciun G, Denu JM: A combinatorial H4 tail library for exploring the histone code. Biochemistry 2008, 47:8094-102.
47. Moyle PM, Muir TW: Method for the synthesis of mono-ADP-ribose conjugated peptides. J Am Chem Soc 2010, 132:15878-80.
48. Gurard-Levin ZA, Mrksich M: The activity of HDAC8 depends on local and distal sequences of its peptide substrates. Biochemistry 2008, 47:6242-50.
49. Kaeberlein M, McDonagh T, Heltweg B, Hixon J, Westman EA, Caldwell SD, Napper A, Curtis R, DiStefano PS, Fields S, Bedalov A, Kennedy BK: Substrate-specific activation of sirtuins by resveratrol. J Biol Chem 2005, 280:17038-45.
50. Gurard-Levin ZA, Scholle MD, Eisenberg AH, Mrksich M: High-throughput screening of small molecule libraries using SAMDI mass spectrometry. ACS Comb Sci 2011, 13:347-50.
51. Plant M, Dineen T, Cheng A, Long AM, Chen H, Morgenstern KA: Screening for lysine-specific demethylase-1 inhibitors using a label-free high-throughput mass spectrometry assay. Anal Biochem 2011, 419:217-27.
52. Ong S, Blagoev B, Kratchmarova I, Kristensen DB, Steen H, Pandey A, Mann M: Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol Cell Proteomics 2002, 1:376-86.
53. Su X, Ren C, Freitas MA: Mass spectrometry-based strategies for characterization of histones and their post-translational modifications. Expert Rev Proteomics 2007, 4:211-25.
54. Tessarz P, Santos-Rosa H, Robson SC, Sylvestersen KB, Nelson CJ, Nielsen ML, Kouzarides T: Glutamine methylation in histone H2A is an RNA-polymerase-I-dedicated modification. Nature 2014, 505:564-8.
55. Tan M, Luo H, Lee S, Jin F, Yang JS, Montellier E, Buchou T, Cheng Z, Rousseaux S, Rajagopal N, Lu Z, Ye Z, Zhu Q, Wysocka J, Ye Y, Khochbin S, Ren B, Zhao Y: Identification of 67 histone marks and histone lysine crotonylation as a new type of histone modification. Cell 2011, 146:1016-28.
56. Ruthenburg AJ, Li H, Milne TA, Dewell S, McGinty RK, Yuen M, Ueberheide B, Dou Y, Muir TW, Patel DJ, Allis CD: Recognition of a mononucleosomal histone modification pattern by BPTF via multivalent interactions. Cell 2011, 145:692-706.
57. Xu C, Cole PA, Meyers DJ, Kormish J, Dent S, Zaret KS: Chromatin "prepattern" and histone modifiers in a fate choice for liver and pancreas. Science 2011, 332:963-6.
58. Zee BM, Young NL, Garcia BA: Quantitative proteomic approaches to studying histone modifications. Curr Chem Genomics 2011, 5:106-14.
59. Garcia BA: Mass spectrometric analysis of histone variants and post-translational modifications. Front Biosci (Schol Ed) 2009, 1:142-53.
60. Eberl HC, Mann M, Vermeulen M: Quantitative proteomics for epigenetics. Chembiochem 2011, 12:224-34.
61. Hayashi-Takanaka Y, Yamagata K, Wakayama T, Stasevich TJ, Kainuma T, Tsurimoto T, Tachibana M, Shinkai Y, Kurumizaka H, Nozaki N, Kimura H: Tracking epigenetic histone modifications in single cells using Fab-based live endogenous modification labeling. Nucleic Acids Res 2011, 39:6475-88.
62. Murphy PJ, Cipriany BR, Wallin CB, Ju CY, Szeto K, Hagarman JA, Benitez JJ, Craighead HG, Soloway PD: Single-molecule analysis of combinatorial epigenomic states in normal and tumor cells. Proc Natl Acad Sci USA 2013, 110:7772-7.
63. Gomez D, Shankman LS, Nguyen AT, Owens GK: Detection of histone modifications at specific gene loci in single cells in histological sections. Nat Methods 2013, 10:171-7.
64. Weibrecht I, Leuchowius K, Clausson C, Conze T, Jarvius M, Howell WM, Kamali-Moghaddam M, Söderberg O: Proximity ligation assays: a recent addition to the proteomics toolbox. Expert Rev Proteomics 2010, 7:401-9.
65. Tagami H, Ray-Gallet D, Almouzni G, Nakatani Y: Histone H3.1 and H3.3 complexes mediate nucleosome assembly pathways dependent or independent of DNA synthesis. Cell 2004, 116:51-61.
66. Campos EI, Fillingham J, Li G, Zheng H, Voigt P, Kuo WW, Seepany H, Gao Z, Day LA, Greenblatt JF, Reinberg D: The program for processing newly synthesized histones H3.1 and H4. Nat Struct Mol Biol 2010, 17:1343-51.
67. Alvarez F, Muñoz F, Schilcher P, Imhof A, Almouzni G, Loyola A: Sequential establishment of marks on soluble histones H3 and H4. J Biol Chem 2011, 286:17714-21.
68. Loyola A, Bonaldi T, Roche D, Imhof A, Almouzni G: PTMs on H3 variants before chromatin assembly potentiate their final epigenetic state. Mol Cell 2006, 24:309-16.
69. Holliday R: DNA methylation and epigenetic inheritance. Philos Trans R Soc Lond B, Biol Sci 1990, 326:329-38.
70. Jasencakova Z, Scharf, Annette N D, Ask K, Corpet A, Imhof A, Almouzni G, Groth A: Replication stress interferes with histone recycling and predeposition marking of new histones. Mol Cell 2010, 37:736-43.
71. Jansen, Lars E T, Black BE, Foltz DR, Cleveland DW: Propagation of centromeric chromatin requires exit from mitosis. J Cell Biol 2007, 176:795-805.
72. Corpet A, Almouzni G: Making copies of chromatin: the challenge of nucleosomal organization and epigenetic information. Trends Cell Biol 2009, 19:29-41.
73. Alabert C, Groth A: Chromatin replication and epigenome maintenance. Nat Rev Mol Cell Biol 2012, 13:153-67.
74. Gurard-Levin ZA, Quivy J, Almouzni G: Histone chaperones: assisting histone traffic and nucleosome dynamics. Annu Rev Biochem 2014, 83:487-517.
75. Groth A, Corpet A, Cook, Adam J L, Roche D, Bartek J, Lukas J, Almouzni G: Regulation of replication fork progression through histone supply and demand. Science 2007, 318:1928-31.
76. Ray-Gallet D, Woolfe A, Vassias I, Pellentz C, Lacoste N, Puri A, Schultz DC, Pchelintsev NA, Adams PD, Jansen, Lars E T, Almouzni G: Dynamics of histone H3 deposition in vivo reveal a nucleosome gap-filling mechanism for H3.3 to maintain chromatin integrity. Mol Cell 2011, 44:928-41.
77. Voigt P, LeRoy G, Drury WJ, Zee BM, Son J, Beck DB, Young NL, Garcia BA, Reinberg D: Asymmetrically modified nucleosomes. Cell 2012, 151:181-93.
78. Lacoste N, Woolfe A, Tachiwana H, Garea AV, Barth T, Cantaloube S, Kurumizaka H, Imhof A, Almouzni G: Mislocalization of the centromeric histone variant CenH3/CENP-A in human cells depends on the chaperone DAXX. Mol Cell 2014, 53:631-44.
79. Adam S, Polo SE, Almouzni G: Transcription recovery after DNA damage requires chromatin priming by the H3.3 histone chaperone HIRA. Cell 2013, 155:94-106.
80. Venkatesh S, Smolle M, Li H, Gogol MM, Saint M, Kumar S, Natarajan K, Workman JL: Set2 methylation of histone H3 lysine 36 suppresses histone exchange on transcribed genes. Nature 2012, 489:452-5.
81. Petruk S, Black KL, Kovermann SK, Brock HW, Mazo A: Stepwise histone modifications are mediated by multiple enzymes that rapidly associate with nascent DNA during replication. Nat Commun 2013, 4:2841.
82. Maison C, Almouzni G: HP1 and the dynamics of heterochromatin maintenance. Nat Rev Mol Cell Biol 2004, 5:296-304.
83. Margueron R, Justin N, Ohno K, Sharpe ML, Son J, Drury WJ, Voigt P, Martin SR, Taylor WR, Marco V de, Pirrotta V, Reinberg D, Gamblin SJ: Role of the polycomb protein EED in the propagation of repressive histone marks. Nature 2009, 461:762-7.
84. Zee BM, Levin RS, Dimaggio PA, Garcia BA: Global turnover of histone post-translational modifications and variants in human cells. Epigenetics Chromatin 2010, 3:22.
85. Barth TK, Imhof A: Fast signals and slow marks: the dynamics of histone modifications. Trends Biochem Sci 2010, 35:618-26.
86. Petruk S, Sedkov Y, Johnston DM, Hodgson JW, Black KL, Kovermann SK, Beck S, Canaani E, Brock HW, Mazo A: TrxG and PcG proteins but not methylated histones remain associated with DNA through replication. Cell 2012, 150:922-33.
87. Jacob Y, Bergamin E, Donoghue, Mark T A, Mongeon V, LeBlanc C, Voigt P, Underwood CJ, Brunzelle JS, Michaels SD, Reinberg D, Couture J, Martienssen RA: Selective methylation of histone H3 variant H3.1 regulates heterochromatin replication. Science 2014, 343:1249-53.
88. Schwartzentruber J, Korshunov A, Liu X, Jones, David T W, Pfaff E, Jacob K, Sturm D, Fontebasso AM, Quang DK, Tönjes M, Hovestadt V, Albrecht S, Kool M, Nantel A, Konermann C, Lindroth A, Jäger N, Rausch T, Ryzhova M, Korbel JO, Hielscher T, Hauser P, Garami M, Klekner A, Bognar L, Ebinger M, Schuhmann MU, Scheurlen W, Pekrun A, Frühwald MC, et al.: Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature 2012, 482:226-31.
89. Fontebasso AM, Papillon-Cavanagh S, Schwartzentruber J, Nikbakht H, Gerges N, Fiset P, Bechet D, Faury D, Jay N de, Ramkissoon LA, Corcoran A, Jones, David T W, Sturm D, Johann P, Tomita T, Goldman S, Nagib M, Bendel A, Goumnerova L, Bowers DC, Leonard JR, Rubin JB, Alden T, Browd S, Geyer JR, Leary S, Jallo G, Cohen K, Gupta N, Prados MD, et al.: Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytoma. Nat Genet 2014, 46:462-6.
90. Taylor KR, Mackay A, Truffaux N, Butterfield YS, Morozova O, Philippe C, Castel D, Grasso CS, Vinci M, Carvalho D, Carcaboso AM, Torres C de, Cruz O, Mora J, Entz-Werle N, Ingram WJ, Monje M, Hargrave D, Bullock AN, Puget S, Yip S, Jones C, Grill J: Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma. Nat Genet 2014, 46:457-61.
91. Buczkowicz P, Hoeman C, Rakopoulos P, Pajovic S, Letourneau L, Dzamba M, Morrison A, Lewis P, Bouffet E, Bartels U, Zuccaro J, Agnihotri S, Ryall S, Barszczyk M, Chornenkyy Y, Bourgey M, Bourque G, Montpetit A, Cordero F, Castelo-Branco P, Mangerel J, Tabori U, Ho KC, Huang A, Taylor KR, Mackay A, Bendel AE, Nazarian J, Fangusaro JR, Karajannis MA, et al.: Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations. Nat Genet 2014, 46:451-6.
92. Müller S, Almouzni G: A network of players in H3 histone variant deposition and maintenance at centromeres. Biochim Biophys Acta 2014, 1839:241-50.
93. Baylin SB, Jones PA: A decade of exploring the cancer epigenome - biological and translational implications. Nat Rev Cancer 2011, 11:726-34.
94. Rius M, Lyko F: Epigenetic cancer therapy: rationales, targets and drugs. Oncogene 2012, 31:4257-65.
95. Rodríguez-Paredes M, Esteller M: Cancer epigenetics reaches mainstream oncology. Nat Med 2011, 17:330-9.
96. Best JD, Carey N: Epigenetic opportunities and challenges in cancer. Drug Discov Today 2010, 15:65-70.
97. Wu G, Diaz AK, Paugh BS, Rankin SL, Ju B, Li Y, Zhu X, Qu C, Chen X, Zhang J, Easton J, Edmonson M, Ma X, Lu C, Nagahawatte P, Hedlund E, Rusch M, Pounds S, Lin T, Onar-Thomas A, Huether R, Kriwacki R, Parker M, Gupta P, Becksfort J, Wei L, Mulder HL, Boggs K, Vadodaria B, Yergeau D, et al.: The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma. Nat Genet 2014, 46:444-50.
98. Lewis PW, Müller MM, Koletsky MS, Cordero F, Lin S, Banaszynski LA, Garcia BA, Muir TW, Becher OJ, Allis CD: Inhibition of PRC2 activity by a gain-of-function H3 mutation found in pediatric glioblastoma. Science 2013, 340:857-61.
99. Black JC, Manning AL, van Rechem C, Kim J, Ladd B, Cho J, Pineda CM, Murphy N, Daniels DL, Montagna C, Lewis PW, Glass K, Allis CD, Dyson NJ, Getz G, Whetstine JR: KDM4A lysine demethylase induces site-specific copy gain and rereplication of regions amplified in tumors. Cell 2013, 154:541-55.
100. Daigle SR, Olhava EJ, Therkelsen CA, Basavapathruni A, Jin L, Boriack-Sjodin PA, Allain CJ, Klaus CR, Raimondi A, Scott MP, Waters NJ, Chesworth R, Moyer MP, Copeland RA, Richon VM, Pollock RM: Potent inhibition of DOT1L as treatment of MLL-fusion leukemia. Blood 2013, 122:1017-25.
101. Bantscheff M, Hopf C, Savitski MM, Dittmann A, Grandi P, Michon A, Schlegl J, Abraham Y, Becher I, Bergamini G, Boesche M, Delling M, Dümpelfeld B, Eberhard D, Huthmacher C, Mathieson T, Poeckel D, Reader V, Strunk K, Sweetman G, Kruse U, Neubauer G, Ramsden NG, Drewes G: Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes. Nat Biotechnol 2011, 29:255-65.
102. Filippakopoulos P, Qi J, Picaud S, Shen Y, Smith WB, Fedorov O, Morse EM, Keates T, Hickman TT, Felletar I, Philpott M, Munro S, McKeown MR, Wang Y, Christie AL, West N, Cameron MJ, Schwartz B, Heightman TD, La Thangue N, French CA, Wiest O, Kung AL, Knapp S, Bradner JE: Selective inhibition of BET bromodomains. Nature 2010, 468:1067-73.
103. Nicodeme E, Jeffrey KL, Schaefer U, Beinke S, Dewell S, Chung C, Chandwani R, Marazzi I, Wilson P, Coste H, White J, Kirilovsky J, Rice CM, Lora JM, Prinjha RK, Lee K, Tarakhovsky A: Suppression of inflammation by a synthetic histone mimic. Nature 2010, 468:1119-23.
104. Singh MM, Manton CA, Bhat KP, Tsai W, Aldape K, Barton MC, Chandra J: Inhibition of LSD1 sensitizes glioblastoma cells to histone deacetylase inhibitors. Neuro-oncology 2011, 13:894-903.
105. Bar-Sela G, Jacobs KM, Gius D: Histone deacetylase inhibitor and demethylating agent chromatin compaction and the radiation response by cancer cells. Cancer J 2007, 13:65-9.
106. Sharma SV, Lee DY, Li B, Quinlan MP, Takahashi F, Maheswaran S, McDermott U, Azizian N, Zou L, Fischbach MA, Wong K, Brandstetter K, Wittner B, Ramaswamy S, Classon M, Settleman J: A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations. Cell 2010, 141:69-80.
107. Sobel RE, Cook RG, Perry CA, Annunziato AT, Allis CD: Conservation of deposition-related acetylation sites in newly synthesized histones H3 and H4. Proc Natl Acad Sci USA 1995, 92:1237-41.
108. Xu M, Long C, Chen X, Huang C, Chen S, Zhu B: Partitioning of histone H3-H4 tetramers during DNA replication-dependent chromatin assembly. Science 2010, 328:94-8.
109. Allis CD, Berger SL, Cote J, Dent S, Jenuwien T, Kouzarides T, Pillus L, Reinberg D, Shi Y, Shiekhattar R, Shilatifard A, Workman J, Zhang Y: New nomenclature for chromatin-modifying enzymes. Cell 2007, 131:633-6.